These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8132376)

  • 21. Clinical and pharmacokinetic aspects of ciprofloxacin in the treatment of acute exacerbations of pseudomonas infection in cystic fibrosis patients.
    Steen HJ; Scott EM; Stevenson MI; Black AE; Redmond AO; Collier PS
    J Antimicrob Chemother; 1989 Nov; 24(5):787-95. PubMed ID: 2599998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
    Langton Hewer SC; Smyth AR
    Cochrane Database Syst Rev; 2009 Oct; (4):CD004197. PubMed ID: 19821321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suboptimal ciprofloxacin dosing as a potential cause of decreased Pseudomonas aeruginosa susceptibility in children with cystic fibrosis.
    Guillot E; Sermet I; Ferroni A; Chhun S; Pons G; Zahar JR; Jullien V
    Pharmacotherapy; 2010 Dec; 30(12):1252-8. PubMed ID: 21114393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy, safety, and potential economic benefits of oral ciprofloxacin in the treatment of infections.
    Sanders WE
    Rev Infect Dis; 1988; 10(3):528-43. PubMed ID: 3293158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral ciprofloxacin compared with conventional intravenous treatment for Pseudomonas aeruginosa infection in adults with cystic fibrosis.
    Hodson ME; Roberts CM; Butland RJ; Smith MJ; Batten JC
    Lancet; 1987 Jan; 1(8527):235-7. PubMed ID: 2880066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ciprofloxacin monotherapy for acute pulmonary exacerbations of cystic fibrosis.
    Goldfarb J; Stern RC; Reed MD; Yamashita TS; Myers CM; Blumer JL
    Am J Med; 1987 Apr; 82(4A):174-9. PubMed ID: 3555032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of ciprofloxacin in the treatment of patients with cystic fibrosis.
    van den Broek PJ; Bakker W; Mattie H; van Gulpen C
    Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S68-71. PubMed ID: 3438152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized study of two dosage regimens of ciprofloxacin for treating chronic bronchopulmonary infection in patients with cystic fibrosis.
    Shalit I; Stutman HR; Marks MI; Chartrand SA; Hilman BC
    Am J Med; 1987 Apr; 82(4A):189-95. PubMed ID: 3555035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.
    Bilton D; Henig N; Morrissey B; Gotfried M
    Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of efficacy and tolerance of intravenously and orally administered ciprofloxacin in cystic fibrosis patients with acute exacerbations of lung infection.
    Strandvik B; Hjelte L; Lindblad A; Ljungberg B; Malmborg AS; Nilsson-Ehle I
    Scand J Infect Dis Suppl; 1989; 60():84-8. PubMed ID: 2756354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antipseudomonal therapy in cystic fibrosis: aztreonam and amikacin versus ceftazidime and amikacin administered intravenously followed by oral ciprofloxacin.
    Schaad UB; Wedgwood-Krucko J; Guenin K; Buehlmann U; Kraemer R
    Eur J Clin Microbiol Infect Dis; 1989 Oct; 8(10):858-65. PubMed ID: 2512129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of ciprofloxacin in patients with cystic fibrosis.
    Bosso JA; Black PG
    Drug Intell Clin Pharm; 1988; 22(7-8):551-3. PubMed ID: 3416737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early Pseudomonas aeruginosa colonisation in cystic fibrosis patients.
    Marchetti F; Candusso M; Faraguna D; Assael BM
    Lancet; 2002 Feb; 359(9306):626-7. PubMed ID: 11867141
    [No Abstract]   [Full Text] [Related]  

  • 34. Safety of ciprofloxacin in children with cystic fibrosis.
    Orenstein DM; Pattishall EN; Noyes BE; Kurland G; Hartigan ER; Yu VL
    Clin Pediatr (Phila); 1993 Aug; 32(8):504-6. PubMed ID: 8403750
    [No Abstract]   [Full Text] [Related]  

  • 35. Sequential intravenous/oral ciprofloxacin in the treatment of severe multiresistant gram-negative infections.
    Chayakul P; Krisanapan S; Kalnauwakul S
    J Med Assoc Thai; 1993 Jan; 76(1):35-40. PubMed ID: 8228692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ciprofloxacin in the treatment of Pseudomonas infection in cystic fibrosis patients.
    Rubio TT; Shapiro C
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():147-52. PubMed ID: 3100490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ciprofloxacin therapy in cystic fibrosis.
    Raeburn JA; Govan JR; McCrae WM; Greening AP; Collier PS; Hodson ME; Goodchild MC
    J Antimicrob Chemother; 1987 Sep; 20(3):295-6. PubMed ID: 3680073
    [No Abstract]   [Full Text] [Related]  

  • 38. Ciprofloxacin: comparative data in cystic fibrosis.
    Rubio TT
    Am J Med; 1987 Apr; 82(4A):185-8. PubMed ID: 3555034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety profile of quinolone antibiotics in the pediatric population.
    Grady R
    Pediatr Infect Dis J; 2003 Dec; 22(12):1128-32. PubMed ID: 14688586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa.
    Scully BE; Neu HC; Parry MF; Mandell W
    Lancet; 1986 Apr; 1(8485):819-22. PubMed ID: 2870313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.